EXCLUSIVE: Penny Stock Medicus Pharma Findings Support Potential In Women’s Health Pipeline

All NewsApril 15, 2026

Medicus Pharma to present Phase 1 Teverelix data showing dose-dependent estradiol suppression and long-acting profile at AACE 2026.

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

EXCLUSIVE: Penny Stock Medicus Pharma Findings Support Potential In Women’s Health Pipeline

The UCW Newswire : Financial, Business and Tech News

Recent Headlines

Walmart has a $160 pop-up canopy with sidewalls for $70

France pressures Germany over nuclear risks of long-range missiles

Ukraine’s freedom must be defended

Inside Ken Griffin’s $5bn Miami takeover

investingLive Asia-Pacific market news: KOSDAQ jumps nearly 5% as AI rebounds, oil firms